Status:
UNKNOWN
P-wave Terminal Force in Patients With Atrial Fibrillation.
Lead Sponsor:
Medical University of Lublin
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-90 years
Brief Summary
It is suggested that P-wave terminal force (Ptf), a product of the amplitude (PAM) and the duration (PT) of the terminal phase of P-wave in lead V1, shows early delay in left atrial conduction, observ...
Detailed Description
Background. It is suggested that P-wave terminal force (Ptf), a product of the amplitude (PAM) and the duration (PT) of the terminal phase of P-wave in lead V1, shows early delay in left atrial conduc...
Eligibility Criteria
Inclusion
- documented atrial fibrillation at admission
- successful restoration of sinus rhythms documented in 12-leads ECG,
- follow-up =\> 5 years
Exclusion
- arrhythmia other than atrial fibrillation at admission,
- unsuccessful restoration of sinus rhythms,
- successful restoration of sinus rhythms but missing 12-leads ECG recording,
- previous ablation/operation within left atrium,
- follow-up \< 5 years
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 7 2020
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03428971
Start Date
March 1 2018
End Date
December 7 2020
Last Update
January 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Lublin
Lublin, Poland, 20-091